• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Systematic Review and Meta-Analysis of Platelet Transfusion Data

May 29, 2015

Platelets, artwork

In the United States, over two million patients receive platelet transfusions each year either prophylactically to reduce the risk of bleeding or therapeutically to control active bleeding.

A new systematic review from 17 randomized clinical trials and 55 observational studies summarizes the platelet transfusion literature focusing on dosage, transfusion thresholds and clinical conditions. The new AABB platelet transfusion guidelines are based on this systematic review. The systematic review also highlights that further research, especially for invasive procedures, is needed to optimize the transfusion of platelets.

References
1. Kumar A, Mhaskar R, Grossman BJ, et al. Platelet transfusion: a systematic review of the clinical evidence. Transfusion 2015;55:1116-27.
2. Wiegmann JD, Mintz PD. The growing role of AABB clinical practice guidelines in improving patient care. Transfusion 2015;55:935-6.

TRF_CMETransfusion offers CME credit for this study! Log on at www.wileyhealthlearning.com/trf.

 

Filed Under

  • CME
  • News
  • Platelet Transfusion

Recommended

  • A Possible Link between RBC Transfusions and Brain Amyloidosis?

  • Expanding U.S. Platelet Supply Needed

  • Time Constraints Deter Blood Donors

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Phosphatidylserine and Phosphatidylethanolamine Levels on RBCs Important for Transfusion Outcomes

  • Blood Donation and Improved Cardiometabolic Health

  • Mitochondrial DNA Acts as a “First Hit” for Antibody-Mediated TRALI

  • Liberal or Restrictive Transfusion Thresholds for Surgery Patients with High Cardiac Risk

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley